Sunshine Biopharma (SBFM) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Sunshine Biopharma Revenue Highlights


Latest Revenue (Y)

$39.85M

Latest Revenue (Q)

$9.30M

Sunshine Biopharma Revenue by Period


Sunshine Biopharma Revenue by Year

DateRevenueChange
2023-12-31$39.85M816.94%
2022-12-31$4.35M1802.41%
2021-12-31$228.43K219.88%
2020-12-31$71.41K238.10%
2019-12-31$21.12K-95.28%
2018-12-31$447.20K100.00%
2017-12-31-100.00%
2016-12-31--100.00%
2015-12-31$1.71K100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-07-31-100.00%
2007-07-31--

Sunshine Biopharma generated $39.85M in revenue during NA 2023, up 816.94% compared to the previous quarter, and up 8910.20% compared to the same period a year ago.

Sunshine Biopharma Revenue by Quarter

DateRevenueChange
2024-06-30$9.30M23.37%
2024-03-31$7.54M-1.81%
2023-12-31$7.68M28.91%
2023-09-30$5.96M7.14%
2023-06-30$5.56M13.62%
2023-03-31$4.89M24.22%
2022-12-31$3.94M2866.57%
2022-09-30$132.81K-11.64%
2022-06-30$150.31K22.55%
2022-03-31$122.64K44.09%
2021-12-31$85.12K68.97%
2021-09-30$50.38K-4.72%
2021-06-30$52.87K31.99%
2021-03-31$40.06K43.00%
2020-12-31$28.01K63.34%
2020-09-30$17.15K13.24%
2020-06-30$15.14K36.42%
2020-03-31$11.10K5.17%
2019-12-31$10.56K44.09%
2019-09-30$7.33K141.54%
2019-06-30$3.03K-97.47%
2019-03-31$119.73K7.05%
2018-12-31$111.84K-18.33%
2018-09-30$136.94K27.68%
2018-06-30$107.25K17.64%
2018-03-31$91.17K171.33%
2017-12-31$33.60K100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--100.00%
2016-12-31$68.14K100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30--100.00%
2015-06-30$1.71K100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-10-31-100.00%
2009-07-31-100.00%
2009-04-30-100.00%
2009-01-31-100.00%
2008-10-31-100.00%
2008-07-31-100.00%
2008-04-30--

Sunshine Biopharma generated $9.30M in revenue during Q2 2024, up 23.37% compared to the previous quarter, and up 190.09% compared to the same period a year ago.

Sunshine Biopharma Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.39M
PAHCPhibro Animal Health$977.89M$263.22M
EGRXEagle Pharmaceuticals$316.61M$64.65M
LFCRLifecore Biomedical$128.26M$24.70M
ALIMAlimera Sciences$80.75M$23.01M
DERMJourney Medical$79.18M$14.86M
SBFMSunshine Biopharma$39.85M$9.30M
TKNOAlpha Teknova$36.68M$9.61M
SNOASonoma Pharmaceuticals$12.73M$3.44M
GHSIGuardion Health Sciences$12.25M$36.35K
SSICSilver Spike Investment$11.72M$2.76B
SXTCChina SXT Pharmaceuticals$1.97M$939.58K
SHPHShuttle Pharmaceuticals--

SBFM Revenue FAQ


Sunshine Biopharma's yearly revenue for 2023 was $39.85M, representing an increase of 816.94% compared to 2022. The company's yearly revenue for 2022 was $4.35M, representing an increase of 1802.41% compared to 2021. SBFM's yearly revenue for 2021 was $228.43K, representing an increase of 219.88% compared to 2020.

Sunshine Biopharma's quarterly revenue for Q2 2024 was $9.3M, a 23.37% increase from the previous quarter (Q1 2024), and a 67.30% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $7.54M, a -1.81% decrease from the previous quarter (Q4 2023), and a 54.09% increase year-over-year (Q1 2023). SBFM's quarterly revenue for Q4 2023 was $7.68M, a 28.91% increase from the previous quarter (Q3 2023), and a 94.94% increase year-over-year (Q4 2022).

Sunshine Biopharma's revenue growth rate for the last 3 years (2021-2023) was 17343.90%, and for the last 5 years (2019-2023) was 188557.75%.